Stonehage Fleming (UK)’s Charles River Laboratories CRL Stock Holding History

Stonehage Fleming (UK)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$2.4M	Hold	29,800	–	–	1.09%	19
2015 Q3	$1.89M	Sell	29,800 -1,500	-5%	-$108K	0.91%	49
2015 Q2	$2.2M	Buy	+31,300	New	+$2.32M	0.99%	24
2014 Q3	–	Sell	-43,500	Closed	-$2.33M	–	316
2014 Q2	$2.33M	Sell	43,500 -9,100	-17%	-$499K	0.94%	45
2014 Q1	$3.17M	Buy	+52,600	New	+$3.07M	1.34%	28

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stonehage Fleming (UK)'s CRL Position: Q4 2015 in Review

Stonehage Fleming (UK) held its Charles River Laboratories (CRL) position steady in Q4 2015 at 29,800 shares worth $2.4M. The position accounts for 1.09% of the portfolio, ranked #19.

Stonehage Fleming (UK) first reported a position in CRL in Q1 2014 and has held it in 5 quarters since. The position peaked at $3.17M in Q1 2014. 268 funds tracked by Wall St. Rank hold CRL as of Q4 2015.

Stonehage Fleming (UK) held 29,800 shares of Charles River Laboratories worth $2.4M as of Q4 2015.
Stonehage Fleming (UK) left its Charles River Laboratories share count unchanged in Q4 2015.
Charles River Laboratories made up 1.09% of Stonehage Fleming (UK)'s portfolio in Q4 2015, its #19 holding.
Stonehage Fleming (UK) first reported a position in Charles River Laboratories in Q1 2014 and has held it in 5 quarters since.
Stonehage Fleming (UK)'s Charles River Laboratories position peaked at $3.17M in Q1 2014.
268 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2015, filed 11 Oct 2019.